Oxidative stress and inflammatory responses of rat following acute inhalation exposure to iron oxide nanoparticles

Human and Experimental Toxicology

Volumn 31, Issue 11, 2012, Pages 1113-1131

  Srinivas, A ^a   Rao, P Jaganmohan ^a   Selvam, G ^a   Goparaju, A ^a   Murthy, Balakrishna P ^a   Reddy, Neelakanta P ^b  

^a International Institute of Biotechnology and Toxicology IIBAT   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

BALF; cytotoxicity; inflammation; inhalation exposure; Iron oxide nanoparticle; oxidative stress; Wistar rat

Indexed keywords

ALKALINE PHOSPHATASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON OXIDE NANOPARTICLE; LACTATE DEHYDROGENASE; MALONALDEHYDE; NANOPARTICLE; PROTEIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; EXPOSURE; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LUNG CLEARANCE; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CATALASE; CYTOKINES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LEUKOCYTE COUNT; MAGNETITE NANOPARTICLES; MALE; OXIDATIVE STRESS; PNEUMONIA; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 84869006534     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112446515     Document Type: Article

References (75)

1. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005 ; 26: 3995-4021
2. Johannsen M, Gnevecko U, Eckel L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia. 2005 ; 21 (7). 637-647
3. Kim D, Hong KS, Song J. The present status of cell tracking methods in animal models using magnetic resonance imaging technology. Mol Cells. 2007 ; 23: 132-137
4. Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2008 ; 24 (6). 467-474
5. Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis. Mol Membr Biol. 2010 ; 27 (7). 274-285
6. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia. 2010 ; 26 (8). 790-795
7. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imagind and potential therapeutic applications in neurooncology and central nervous system inflammatory paathologies, a review. J Cereb Blood Flow Metab. 2010 ; 30 (1). 15-35
8. Vetter A, Reinisch A, Strunk D, et al. Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells. J Drug Targ. 2011 ;: 1-11
9. Series on the safety of manufactured nanomaterials.
10. Apopa PL, Qian Y, Shao R, et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol. 2009 ; 6: 1
11. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005 ; 19: 975-983
12. Cho WS, Cho M, Kim SR, et al. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Toxicol Appl Pharmacol. 2009 ; 239 (1). 106-115
13. Park EJ, Kim H, Kim Y, et al. Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology. 2010 ; 275: 65-71
14. Pettibone JM, Adamcakova-Dodd A, Thorne PS, et al. Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology. 2008 ; 2 (4). 189-204
15. Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006 ; 4 (12). 2699-2711
16. Karlsson HL, Cronholm P, Gustafsson J, Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. 2008 ; 21 (9). 1726-1732
17. Shen S, Liu Y, Huang P, Wang J. In vitro cellular uptake and effects of Fe3O4 magnetic nanoparticles on HeLa cells. J Nanosci Nanotechnol. 2009 ; 9 (5). 2866-2871
18. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007 ; 97 (1). 163-180
19. Moore A, Marecos E, Bogdanov , Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 2000 ; 214: 568-574
20. Landeghem FKH, Maier-Hauff K, Jordan A, et al. A post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials. 2009 ; 30: 52-57
21. Osier M, Oberdörster G. Intratracheal inhalation vs. intratracheal instillation: differences in particle effects. Fundam Appl Toxicol. 1997 ; 40: 220-227
22. Driscoll KE, Carter JM, Hassenbein DG, Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect. 1997 ; 105: 1159-1164
23. Madl AK, Pinkerton KE. Health effects of inhaled engineered and incidental nanoparticles. Criti Rev Toxicol. 2009 ; 39 (8). 629-658
24. Paris: OECD ; 2009 :
25. Byun JA, Ryu MH, Lee JK. The immunomodulatory effects of 3 monochloro-1,2-propanediol on murine splenocyte and peritoneal macrophage function in vitro. Toxicol In Vitro. 2006 ; 20: 272-278
26. Srinivas A, Rao PJ, Selvaza G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett. 2011 ; 205: 105-115
27. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. J Biochem Biophy. 1984 ; 21: 130-132
28. Aebi H Methods in enzymatic analysis. Bergmeyer HV, ed. New York: Academic Press ; 1974: 674-684.
29. Park EJ, Yoon J, Choi K, Yi J, Park K. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology. 2009 ; 260: 37-46
30. Dhawan A, Sharma V, Parmar D. Nanomaterials: a challenge for toxicologists. Nanotoxicology. 2009 ; 3: 1-9
31. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008 ; 101: 239-253
32. Warheit DB. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?. Toxicol Sci. 2008 ; 101: 183-185
33. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005 ; 113: 823-839
34. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nano level. Science. 2006 ; 311: 622-627
35. Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radical Biol Med. 2008 ; 44: 1689-1699
36. Park EJ, Choi J, Park Y, Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology. 2008 ; 245: 90-100
37. Akhtar MJ, Kumar S, Murthy RC, et al. The primary role of iron-mediated lipid peroxidation in the differential cytotoxicity caused by two varieties of talc nanoparticles on A549 cells and lipid peroxidation inhibitory effect exerted by ascorbic acid. Toxicol In Vitro. 2010 ; 24: 1139-1147
38. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology. 2007 ; 230: 90-104
39. Shvedova AA, Kisin E, Murray AR, et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol. 2008 ; 295: 1-16
40. Morimoto Y, Ogami A, Todoroki M, et al. Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles. Nanotoxicology. 2010 ; 4 (2). 161-176
41. Gillespie PA, Kang GS, Elder A, et al. Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice. Nanotoxicology. 2010 ; 4 (1). 106-119
42. Muller J, Huaux F, Moreau N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharm. 2005 ; 207: 221-231
43. Lay JC, Bennett WD, Ghio AJ, et al. Cellular and biochemical response of the human lung after intrapulmonary instillation of ferric oxide particles. Am J Respir Cell Mol Biol. 1999 ; 20: 631-642
44. Rice TM, Clarke RW, Godleski JJ, et al. Differential ability of transition metals to induce pulmonary inflammation. Toxicol Appl Pharmacol. 2001 ; 177: 46-53
45. Aust AE, Ball JC, Hu A, Lighty JAS, Smith KR. Particle characteristics responsible for effects on human lung epithelial cells. Res Rep Health Eff Inst. 2002 ; 110: 1-65
46. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997 ; 2: 12-26
47. Driscoll KE, Costa DL, Hatch G, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000 ; 55: 24-35
48. Ayyagari VN, Januszkiewicz A, Nath J. Pro-inflammatory responses of human bronchial epithelial cells to acute nitrogen dioxide exposure. Toxicology. 2004 ; 197: 148-163
49. Teruel A, Romero M, Cacalano NA, Head C, Jewett A. Potential contribution of naive immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion. Cancer Immunol Immun. 2008 ; 57: 359-366
50. Wang JX, Liu Y, Jiao F, et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology. 2008 ; 254: 82-90
51. Zhu MT, Feng WY, Wang B, et al. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology. 2008 ; 247: 102-111
52. Motulsky HJ Prism 4 statistics guide-statistical analyses for laboratory and clinical researchers. San Diego CA: GraphPad Software Inc ; 2003: 92-95.
53. Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000 ; 153: 83-104
54. Zhang R, Niu Y, Li Y, et al. Acute toxicity study of the interaction between titanium dioxide nanoparticles and lead acetate in mice. Environ Toxicol Pharmacol. 2010 ; 30: 52-60
55. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology. 2002 ;: 181 219-182 222
56. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, Marnett LJ. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem. 2003 ; 278: 31426-31433
57. Nordberg J, Arner ES. Reactive oxygen species, antioxidants and the mammalian thioredoxin system. Free Radical Biol Med. 2001 ; 31: 1287-1312
58. Pauluhn J. Comparative pulmonary response to inhaled nanostructures: considerations on test design and endpoints. Inhalation Toxicology. 2009 ; 21 (S1). 40-54
59. Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005 ; 113 (11). 1555-1560
60. Semmler-Behnke M, Takenaka S, Fertsch S, et al. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect. 2007 ; 115: 728-733
61. Kaewamatawong T, Kawamura N, Okajima M, et al. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol Path. 2005 ; 33: 743-749
62. Fujiwara K, Suematsu H, Kiyomiya E, et al. Size-dependent toxicity of silica nano-particles to Chlorella kessleri. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2008 ; 43: 1167-1173
63. Karlsson HL, Gustafsson J, Cronholm P, Möller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol Lett. 2009 ; 188: 112-118
64. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci. 2009 ; 109: 152-167
65. Nemmar A, Hoet PHM, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002 ; 105: 411-414
66. Oberdörster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002 ; 65: 1531-1543
67. Oberdörster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004 ; 16: 437-445
68. Elder A, Gelein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006 ; 114: 1172-1178
69. Peters A, Veronesi B, Calderon-Garciduenas L, et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol. 2006 ; 3: 13
70. Shimada A, Kawamura N, Okajima M, et al. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol Path. 2006 ; 34: 949-957
71. Hirst SM, Karakoti AS, Tyler RD, et al. Anti-inflammatory properties of cerium oxide nanoparticles. Small. 2009 ; 5: 2848-2856
72. Brown JS, Zeman KL, Bennett WD. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 2002 ; 166: 1240-1247
73. Kreyling WG, Semmler M, Erbe F, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002 ; 65: 1513-1530
74. Semmler-Behnke M, Seitz J, Erbe F, et al. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol. 2004 ; 16: 453-459
75. Wiebert P, Sanchez-Crespo A, Seitz J, et al. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Europ Respir J. 2006 ; 28: 286-290